WHO says too early to comment on remdesivir coronavirus trials
It is too early to comment on the remdesivir “positive data” trial results released earlier on Wednesday, said Dr.…
Browsing Tag
Gilead Sciences
U.S. FDA in ‘ongoing’ talks Gilead to make remdesivir available to coronavirus patients…
The U.S. Food and Drug Administration (FDA) said on Wednesday it has been in “sustained and ongoing” talks with…
Trump urges FDA to approve remdesivir ‘as quickly as they can’
U.S. President Donald Trump said on Wednesday he wants the Food and Drug Administration to approve “as quickly as…
Gilead sees ‘positive data’ on remdesivir coronavirus drug trial
US Gilead Sciences it is aware of “positive data” from one of its studies looking at antiviral drug remdesivir as a…
Japan says to approve Gilead’s remdesivir to treat coronavirus patients
Japan announced on Tuesday that it would approve remdesivir, a antiviral drug made by U.S. firm Gilead Sciences,…
New data on Gilead’s remdesivir – released by accident – shows it flops in first…
Remdesivir developed by Gilead Sciences, a potential antiviral drug to treat coronavirus, has failed in its first…
